A critical review in BMC Medical Research Methodology argues ClinicalTrials.gov needs structural improvements beyond regulatory compliance to address data quality, usability, and adherence to reporting standards. Authors Alejandro Rivero-de-Aguilar and colleagues identify six domains where the registry could be strengthened, including eligibility structure, methodological fields, results presentation, and patient-centered participation details.